4//SEC Filing
Sigal Charles Elliott 4
Accession 0001104659-22-076896
CIK 0001621227other
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 5:01 PM ET
Size
5.5 KB
Accession
0001104659-22-076896
Insider Transaction Report
Form 4
Sigal Charles Elliott
Director
Transactions
- Award
Option to purchase Ordinary Shares
2022-07-01+737,050→ 737,050 totalExercise: $0.28From: 2023-07-01Exp: 2032-07-02→ Ordinary Shares (737,050 underlying)
Footnotes (1)
- [F1]The exercise price was converted from GBP0.23 based on an exchange rate of $U.S. 1.216007 to GBP1.00. The actual exercise price will be the pounds sterling amount.
Documents
Issuer
Adaptimmune Therapeutics PLC
CIK 0001621227
Entity typeother
Related Parties
1- filerCIK 0001661908
Filing Metadata
- Form type
- 4
- Filed
- Jun 30, 8:00 PM ET
- Accepted
- Jul 1, 5:01 PM ET
- Size
- 5.5 KB